Overcoming Barriers to Prevention, Care, and Treatment of Hepatitis C in Illicit Drug Users

Citations Over TimeTop 10% of 2005 papers

Abstract

Injection drug use accounts for most of the incident infections with hepatitis C virus (HCV) in the United States and other developed countries. HCV infection is a complex and challenging medical condition in injection drug users (IDUs). Elements of care for hepatitis C in illicit drug users include prevention counseling and education; screening for transmission risk behavior; testing for HCV and human immunodeficiency virus infection; vaccination against hepatitis A and B viruses; evaluation for comorbidities; coordination of substance-abuse treatment services, psychiatric care, and social support; evaluation of liver disease; and interferon-based treatment for HCV infection. Caring for patients who use illicit drugs presents challenges to the health-care team that require patience, experience, and an understanding of the dynamics of substance use and addiction. Nonetheless, programs are successfully integrating hepatitis C care for IDUs into health-care settings, including primary care, methadone treatment and other substance-abuse treatment programs, infectious disease clinics, and clinics in correctional facilities.

Related Papers

• → Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels(2013)180 cited
• → Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection(2017)175 cited
• → High Prevalence of Hepatitis C Virus Type 5 in Central France Evidenced by a Prospective Study from 1996 to 2002(2004)54 cited
• → Failure of Hepatitis C Therapy in HIV‐Coinfected Drug Users Is Not Due to a Shift in Hepatitis C Virus Genotype(2005)8 cited
• → Treatment of Hepatitis C Virus in the Coinfected Patient(2003)3 cited